Skip to main content

Table 1 Dose constraints

From: Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial

OAR

Constraint

Urethra + 2 mm

D0.2 cc ≤ 37.5 Gy

Bladder

D0.2 cc ≤ 38.5 Gy

 

Dmean ≤ 25 Gy

Rectum

D0.2 cc ≤ 38.5 Gy

Bowel

D0.5 cc ≤ 35 Gy

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us